Management of Eclampsia with PRES in the Postpartum Period

Immediate Seizure Management

The American College of Obstetricians and Gynecologists recommends administering magnesium sulfate immediately using the dosing regimen from the Eclampsia and MAGPIE trials: 4-5g IV loading dose over 5-10 minutes, followed by 1-2g/hour continuous infusion 1, 2
Magnesium sulfate should be continued for 24 hours postpartum, as this is the standard duration recommended despite some controversy about shorter durations 2

The European Society of Cardiology recommends treating blood pressure ≥160/110 mmHg lasting >15 minutes immediately to prevent cerebrovascular complications 3, 1
First-line IV agents for acute severe hypertension include IV labetalol, oral nifedipine, and IV hydralazine, with specific dosing regimens 1, 4, 3
The American Heart Association recommends maintaining systolic BP <160 mmHg and diastolic BP <110 mmHg throughout the postpartum period 3, 1

The American College of Obstetricians and Gynecologists recommends monitoring blood pressure every 4-6 hours while awake for a minimum of 3 days postpartum 2, 5, 1
Neurological status should be monitored continuously for headache, visual disturbances, altered mental status, and signs of worsening cerebral edema 5, 1

The American College of Obstetricians and Gynecologists recommends avoiding the use of NSAIDs for pain control in women with preeclampsia/eclampsia, especially with acute kidney injury, as they can worsen hypertension and renal function 2, 1
Women should not be discharged before 24 hours postpartum or until vital signs are stable and neurological symptoms have resolved 1

The European Society of Cardiology recommends continuing or restarting antihypertensive medications postpartum and tapering slowly only after days 3-6, unless BP becomes low (<110/70 mmHg) or patient becomes symptomatic 2, 5
Preferred oral agents for breastfeeding mothers include labetalol, nifedipine, and methyldopa 5, 4, 3

The American College of Obstetricians and Gynecologists recommends that most women can be discharged by day 5 postpartum if blood pressure is controlled and they can monitor BP at home 2, 5
Mandatory follow-up at 6 weeks postpartum is recommended to confirm normalization of BP, urinalysis, and laboratory tests 2, 5

The American Heart Association recommends reviewing all women at 3 months postpartum to ensure complete resolution of hypertension and proteinuria 2, 5, 1
Women with persistent hypertension or proteinuria at 6 weeks should be referred to a specialist, as this may indicate underlying renal disease or secondary hypertension requiring further workup 2, 3, 5

The European Society of Cardiology recommends treating blood pressure ≥160/110 mmHg lasting >15 minutes immediately with IV antihypertensives to prevent stroke and cerebrovascular complications 6
IV labetalol is the preferred first-line agent for rapid BP control, according to the European Heart Journal 6
Oral nifedipine is an effective alternative for immediate-release, as stated by the European Heart Journal 6
The European Heart Journal warns to never administer calcium channel blockers (nifedipine) concomitantly with magnesium sulfate due to risk of severe hypotension from synergistic effects 6

Monitor for early warning signs of pulmonary edema: tachycardia, oliguria, and elevated hematocrit, as recommended by the European Heart Journal 6

The European Heart Journal recommends preferred oral agents for breastfeeding mothers: labetalol, nifedipine, enalapril, metoprolol, and methyldopa 6
The European Heart Journal advises not to use methyldopa for urgent BP reduction—it is too slow-acting for acute management 6